Skip to main content

Characterisation of Hepatocellular Carcinoma in Cirrhosis

  • Chapter

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Parkin DM, Pisani P, Ferlay J (1990) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827–841

    Article  Google Scholar 

  2. Taura N, Hamasaki K, Nakao K et al (2005) Clinical benefits of hepatocellular carcinoma surveillance: A single-center, hospital-based study. Oncol Rep 14:999–1003

    PubMed  Google Scholar 

  3. Sala M, Llovet JM, Vilana R et al (2004) Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40:1352–1360

    Article  PubMed  Google Scholar 

  4. Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J. Hepatol. 35:421–430

    Article  PubMed  CAS  Google Scholar 

  5. Kojiro M, Roskams T (2005) Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis 25:133–142

    Article  PubMed  Google Scholar 

  6. Roncalli M, Roz E, Coggi G et al (1999)The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 30: 1174–1178

    Article  PubMed  CAS  Google Scholar 

  7. Borzio M, Fargion S, Borzio F et al (2003) Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol 39:208–214

    Article  PubMed  Google Scholar 

  8. Terjung B, Lemnitzer I, Dumoulin FL et al (2003) Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion 67:138–145

    Article  PubMed  Google Scholar 

  9. Torzilli G, Minagawa M, Takayama T et al (1999) Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 30:889–893

    Article  PubMed  CAS  Google Scholar 

  10. Zoli M, Magalotti D, Bianchi G et al (1996) Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 78:977–985

    Article  PubMed  CAS  Google Scholar 

  11. Oka H, Yamamoto S, Kuroki T et al (1990) Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 12:680–687

    PubMed  CAS  Google Scholar 

  12. Bennett GL, Krinsky GA, Abitbol RJ et al (2002) Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients. AJR Am J Roentgenol 179:75–80

    PubMed  Google Scholar 

  13. Shapiro RS, Wagreich J, Parsons RB et al (1998) Tissue harmonic imaging sonography: evaluation of image quality compared with conventional sonography. AJR Am J Roentgenol. 171:1203–1206

    PubMed  CAS  Google Scholar 

  14. Tanaka S, Oshikawa O, Sasaki T et al (2000) Evaluation of tissue harmonic imaging for the diagnosis of focal liver lesions. Ultrasound Med Biol 26:183–187

    Article  PubMed  CAS  Google Scholar 

  15. Sheu JC, Chen DS, Sung JL et al (1985) Hepatocellular carcinoma: US evolution in the early stage. Radiology 155:463–467

    PubMed  CAS  Google Scholar 

  16. Kim KA, Lee WJ, Lim HK et al (2003) Small hepatocellular carcinoma: ultrasonographic findings and histopathologic correlation. Clin Imaging 27:340–345

    Article  PubMed  CAS  Google Scholar 

  17. Ogata R, Majima Y, Tateishi Y et al (2000) Bright loop appearance; a characteristic ultrasonography sign of early hepatocellular carcinoma. Oncol Rep 7:1293–1298

    PubMed  CAS  Google Scholar 

  18. Bru C, Maroto A, Bruix J et al (1989) Diagnostic accuracy of fine-needle aspiration biopsy in patients with hepatocellular carcinoma. Dig Dis Sci 34:1765–1769

    Article  PubMed  CAS  Google Scholar 

  19. Lencioni R, Pinto F, Armillotta N, Bartolozzi C (1996) Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US. Radiology 201:353–358

    PubMed  CAS  Google Scholar 

  20. Koito K, Namieno T, Morita K (1998) Differential diagnosis of small hepatocellular carcinoma and adenomatous hyperplasia with power Doppler sonography. AJR Am J Roentgenol 170:157–161

    PubMed  CAS  Google Scholar 

  21. Kumada T, Nakano S, Toyoda H et al (2004) Assessment of tumor hemodynamics in small hepatocellular carcinoma: comparison of Doppler ultrasonography, angiography-assisted computed tomography, and pathological findings. Liver Int 24:425–431

    Article  PubMed  Google Scholar 

  22. Gaiani S, Volpe L, Piscaglia F, Bolondi L (2001) Vascularity of liver tumours and recent advances in doppler ultrasound. J Hepatol 34:474–482

    Article  PubMed  CAS  Google Scholar 

  23. Kudo M, Tochio H, Zhou P (2004) Differentiation of hepatic tumors by color Doppler imaging: role of the maximum velocity and the pulsatility index of the intratumoral blood flow signal. Intervirology 47:154–161

    Article  PubMed  Google Scholar 

  24. Fracanzani AL, Burdick L, Borzio M et al (2001) Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology 34:1109–1112

    Article  PubMed  CAS  Google Scholar 

  25. Valls C, Cos M, Figueras J et al (2004) Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT. AJR Am J Roentgenol 182:1011–1017

    PubMed  Google Scholar 

  26. Yamashita Y, Mitsuzaki K, Yi T et al (1996) Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 200:79–84

    PubMed  CAS  Google Scholar 

  27. Nicolau C, Catala V, Vilana R et al (2004) Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 14:1092–1099

    Article  PubMed  Google Scholar 

  28. Quaia E, Calliada F, Bertolotto M et al (2004) Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232:420–430

    PubMed  Google Scholar 

  29. Nicolau C, Vilana R, Catala V et al (2006) The importance of the evaluation of all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol 186(1):158–167

    Article  PubMed  Google Scholar 

  30. Vilana R, Llovet JM, Bianchi L et al (2003) Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation. J Clin Ultrasound 31:119–128

    Article  PubMed  Google Scholar 

  31. Giorgio A, Ferraioli G, Tarantino L et al (2004) Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance. AJR Am J Roentgenol 183:1319–1326

    PubMed  Google Scholar 

  32. Gaiani S, Celli N, Piscaglia F et al (2004) Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 41:421–426

    Article  PubMed  Google Scholar 

  33. Choi BI, Kim TK, Han JK et al (2000) Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US. Radiology 214:381–386

    PubMed  CAS  Google Scholar 

  34. Bolondi L, Gaiani S, Celli N et al (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27–34

    Article  PubMed  Google Scholar 

  35. Matsui O (2004) Imaging of multistep human hepatocarcinogenesis by CT during intra-arterial contrast injection. Intervirology 47:271–276

    Article  PubMed  Google Scholar 

  36. Takayasu K, Muramatsu Y, Furukawa H et al (1995) Early hepatocellular carcinoma: appearance at CT during arterial portography and CT arteriography with pathologic correlation. Radiology 194:101–105

    PubMed  CAS  Google Scholar 

  37. Kim T, Federle MP, Baron RL et al (2001) Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology 219:699–706

    PubMed  CAS  Google Scholar 

  38. Hayashi PH, Trotter JF, Forman L et al (2004) Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD. Liver Transpl 10:42–48

    Article  PubMed  Google Scholar 

  39. Albrecht T, Blomley M, Bolondi L et al (2004) Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 25:249–256

    Article  PubMed  CAS  Google Scholar 

  40. Marrero JA, Hussain HK, Nghiem HV et al (2005) Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 11:281–289

    Article  PubMed  Google Scholar 

  41. Dietrich CF, Ignee A, Trojan J et al (2004) Improved characterisation of histologically proven liver tumours by contrast-enhanced ultrasonography during the portal-venous and specific late phase of SHU 508A. Gut 53:401–405

    Article  PubMed  CAS  Google Scholar 

  42. von Herbay A, Vogt C, Willers R, Haussinger D (2004) Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 23:1557–1568

    Google Scholar 

  43. Vilana R, Bru C, Bruix J et al (1993) Fine-needle aspiration biopsy of portal vein thrombus: value in detecting malignant thrombosis. AJR Am J Roentgenol 160:1285–1287

    PubMed  CAS  Google Scholar 

  44. Dodd GD III, Memel DS, Baron RL et al (1995) Portal vein thrombosis in patients with cirrhosis: does sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus? AJR Am J Roentgenol 165:573–577

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Italia

About this chapter

Cite this chapter

Nicolau, C., Bru, C. (2006). Characterisation of Hepatocellular Carcinoma in Cirrhosis. In: Lencioni, R. (eds) Enhancing the Role of Ultrasound with Contrast Agents. Springer, Milano. https://doi.org/10.1007/88-470-0476-4_3

Download citation

  • DOI: https://doi.org/10.1007/88-470-0476-4_3

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0475-7

  • Online ISBN: 978-88-470-0476-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics